Literature DB >> 15226608

Effect of ionizing irradiation on human esophageal cancer cell lines by cDNA microarray gene expression analysis.

Hideki Bo1, Mohammad Ghazizadeh, Hajime Shimizu, Yuji Kurihara, Seiko Egawa, Yukichi Moriyama, Takashi Tajiri, Oichi Kawanami.   

Abstract

To provide new insights into the molecular mechanisms underlying the effect of irradiation on esophageal squamous cell carcinomas (ESCCs), we used a cDNA microarray screening of more than 4,000 genes with known functions to identify genes involved in the early response to ionizing irradiation. Two human ESCC cell lines, one each of well (TE-1) and poorly (TE-2) differentiated phenotypes were screened. Subconfluent cells of each phenotype were treated with single doses of 2.0 Gy or 8.0 Gy irradiations. After a 15 min incubation time-point, the cells were collected and analyzed. Compared with non-irradiated cells, many genes revealed at least 2-fold upregulation or downregulation at both doses in well or poorly differentiated ESCC cells. The common upregulated genes in well and poorly differentiated cell types at both irradiation doses included SCYA5, CYP51, SMARCD2, COX6C, MAPK8, FOS, UBE2M, RPL6, PDGFRL, TRAF2, TNFAIP6, ITGB4, GSTM3, and SP3 and common downregulated genes involved NFIL3, SMARCA2, CAPZA1, MetAP2, CITED2, DAP3, MGAT2, ATRX, CIAO1, and STAT6. Several of these genes were novel and not previously known to be associated with irradiation. Functional annotations of the modulated genes suggested that at the molecular level, irradiation appears to induce a regularizing balance in ESCC cell function. The genes modulated in the early response to irradiation may be useful in our understanding of the molecular basis of radiotherapy and in developing strategies to augment its effect or establish novel less hazardous alternative adjuvant therapies.

Entities:  

Mesh:

Year:  2004        PMID: 15226608     DOI: 10.1272/jnms.71.172

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  17 in total

Review 1.  cDNA microarray analysis of esophageal cancer: discoveries and prospects.

Authors:  Yutaka Shimada; Fumiaki Sato; Kazuharu Shimizu; Gozoh Tsujimoto; Kazuhiro Tsukada
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-07-14

Review 2.  Differential expression and clinical significance of COX6C in human diseases.

Authors:  Bi-Xia Tian; Wei Sun; Shu-Hong Wang; Pei-Jun Liu; Yao-Chun Wang
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

Review 3.  Inactivation of X-linked tumor suppressor genes in human cancer.

Authors:  Runhua Liu; Mandy Kain; Lizhong Wang
Journal:  Future Oncol       Date:  2012-04       Impact factor: 3.404

4.  Current gene expression studies in esophageal carcinoma.

Authors:  Wei Guo; Yao-Guang Jiang
Journal:  Curr Genomics       Date:  2009-12       Impact factor: 2.236

5.  Regulation of mitochondrial ribosomal protein S29 (MRPS29) expression by a 5'-upstream open reading frame.

Authors:  Min-Joon Han; Daniel T Chiu; Emine C Koc
Journal:  Mitochondrion       Date:  2010-01-14       Impact factor: 4.160

6.  Assessment of ATRX expression in patients with myelodysplastic syndromes treated with decitabine.

Authors:  David P Steensma; Julie C Porcher; Mark R Litzow; William J Hogan; Sujata Arora; Emily S Van Laar
Journal:  Leuk Res       Date:  2009-01-20       Impact factor: 3.156

7.  Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells.

Authors:  Ping Yin; Damian Roqueiro; Lei Huang; Jonas K Owen; Anna Xie; Antonia Navarro; Diana Monsivais; John S Coon; J Julie Kim; Yang Dai; Serdar E Bulun
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

8.  Inactivating UBE2M impacts the DNA damage response and genome integrity involving multiple cullin ligases.

Authors:  Scott Cukras; Nicholas Morffy; Takbum Ohn; Younghoon Kee
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

9.  NC2213: a novel methionine aminopeptidase 2 inhibitor in human colon cancer HT29 cells.

Authors:  Ponniah Selvakumar; Ashakumary Lakshmikuttyamma; Umashankar Das; Hari N Pati; Jonathan R Dimmock; Rajendra K Sharma
Journal:  Mol Cancer       Date:  2009-08-24       Impact factor: 27.401

10.  New Frontiers for the NFIL3 bZIP Transcription Factor in Cancer, Metabolism and Beyond.

Authors:  Megan Keniry; Robert K Dearth; Michael Persans; Ramon Parsons
Journal:  Discoveries (Craiova)       Date:  2014 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.